Intranigral injected iron progressively reduces striatal dopamine metabolism

J Neural Transm Park Dis Dement Sect. 1994;8(3):209-14. doi: 10.1007/BF02260941.

Abstract

The striatal dopamine metabolism of the rat was followed 1, 3, and 6 weeks after unilateral intranigral iron (III) (50- and 1.5 micrograms) application. For both concentrations a progredient decrease of extraneuronal 3.4-dihydroxyphenylacetic acid (DOPA) levels was observed in the ipsilateral striatum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism*
  • Animals
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Dopamine / metabolism*
  • Ferric Compounds / administration & dosage
  • Ferric Compounds / pharmacology*
  • Injections
  • Male
  • Parkinson Disease / metabolism
  • Rats
  • Rats, Wistar
  • Substantia Nigra / drug effects*

Substances

  • Ferric Compounds
  • 3,4-Dihydroxyphenylacetic Acid
  • Dopamine